| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Premenstrual Syndrome | 25 | 2024 | 96 | 9.190 |
Why?
|
| Menopause | 22 | 2024 | 246 | 6.810 |
Why?
|
| Menopause, Premature | 9 | 2023 | 25 | 4.080 |
Why?
|
| Vitamin D | 16 | 2022 | 149 | 4.000 |
Why?
|
| Anti-Mullerian Hormone | 12 | 2024 | 62 | 3.990 |
Why?
|
| Diet | 22 | 2024 | 635 | 3.880 |
Why?
|
| Prospective Studies | 60 | 2024 | 3101 | 3.460 |
Why?
|
| Postmenopause | 17 | 2022 | 246 | 2.820 |
Why?
|
| Risk Factors | 63 | 2024 | 5016 | 2.730 |
Why?
|
| Female | 139 | 2024 | 30918 | 2.700 |
Why?
|
| Adult | 93 | 2024 | 15787 | 2.500 |
Why?
|
| Depression | 14 | 2024 | 857 | 2.180 |
Why?
|
| Premenopause | 11 | 2024 | 57 | 2.160 |
Why?
|
| Breast Feeding | 3 | 2024 | 138 | 2.020 |
Why?
|
| Humans | 146 | 2024 | 59517 | 1.940 |
Why?
|
| Body Mass Index | 22 | 2024 | 886 | 1.900 |
Why?
|
| Hot Flashes | 3 | 2024 | 95 | 1.880 |
Why?
|
| Dietary Proteins | 3 | 2019 | 55 | 1.800 |
Why?
|
| Menarche | 3 | 2024 | 34 | 1.790 |
Why?
|
| Case-Control Studies | 24 | 2024 | 1063 | 1.770 |
Why?
|
| Nurses | 11 | 2024 | 103 | 1.720 |
Why?
|
| Self Report | 10 | 2024 | 366 | 1.710 |
Why?
|
| Young Adult | 36 | 2024 | 4331 | 1.670 |
Why?
|
| Exercise | 8 | 2018 | 916 | 1.620 |
Why?
|
| Sterilization, Tubal | 2 | 2021 | 10 | 1.530 |
Why?
|
| Middle Aged | 57 | 2024 | 16276 | 1.450 |
Why?
|
| Dietary Fats | 5 | 2023 | 204 | 1.430 |
Why?
|
| Surveys and Questionnaires | 29 | 2024 | 2592 | 1.430 |
Why?
|
| Parity | 3 | 2021 | 71 | 1.420 |
Why?
|
| Inflammation | 9 | 2023 | 1102 | 1.420 |
Why?
|
| Calcium, Dietary | 4 | 2017 | 43 | 1.370 |
Why?
|
| Breast | 4 | 2022 | 173 | 1.350 |
Why?
|
| Breast Neoplasms | 12 | 2022 | 1129 | 1.340 |
Why?
|
| Menstrual Cycle | 8 | 2024 | 77 | 1.280 |
Why?
|
| Feeding Behavior | 5 | 2024 | 314 | 1.280 |
Why?
|
| Adolescent | 32 | 2024 | 5932 | 1.270 |
Why?
|
| Age Factors | 11 | 2024 | 1518 | 1.220 |
Why?
|
| Cholecalciferol | 4 | 2022 | 27 | 1.220 |
Why?
|
| Proportional Hazards Models | 13 | 2024 | 673 | 1.210 |
Why?
|
| Cross-Sectional Studies | 27 | 2024 | 2470 | 1.190 |
Why?
|
| Sexual and Gender Minorities | 3 | 2024 | 73 | 1.190 |
Why?
|
| Cohort Studies | 19 | 2024 | 2442 | 1.180 |
Why?
|
| Women's Health | 6 | 2022 | 390 | 1.180 |
Why?
|
| Stress, Psychological | 7 | 2024 | 443 | 1.160 |
Why?
|
| Bone Density | 4 | 2013 | 173 | 1.150 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2018 | 78 | 1.150 |
Why?
|
| Nutritional Status | 2 | 2018 | 118 | 1.140 |
Why?
|
| Health Surveys | 3 | 2024 | 306 | 1.120 |
Why?
|
| Premature Birth | 5 | 2022 | 108 | 1.080 |
Why?
|
| Odds Ratio | 13 | 2023 | 773 | 1.060 |
Why?
|
| Emotions | 4 | 2021 | 217 | 1.060 |
Why?
|
| Calcium | 4 | 2017 | 556 | 1.040 |
Why?
|
| Fatty Acids | 3 | 2023 | 194 | 0.980 |
Why?
|
| Interleukin-10 | 3 | 2023 | 147 | 0.970 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 169 | 0.960 |
Why?
|
| Heterosexuality | 1 | 2024 | 9 | 0.960 |
Why?
|
| Alcohol Drinking | 3 | 2021 | 299 | 0.960 |
Why?
|
| Adiposity | 3 | 2022 | 79 | 0.950 |
Why?
|
| Contraceptives, Oral | 2 | 2021 | 25 | 0.950 |
Why?
|
| C-Reactive Protein | 8 | 2023 | 167 | 0.940 |
Why?
|
| Cigarette Smoking | 3 | 2021 | 52 | 0.930 |
Why?
|
| Vitamins | 5 | 2022 | 83 | 0.920 |
Why?
|
| Dietary Supplements | 9 | 2022 | 247 | 0.910 |
Why?
|
| Dairy Products | 4 | 2019 | 27 | 0.900 |
Why?
|
| Logistic Models | 13 | 2023 | 1252 | 0.900 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 827 | 0.880 |
Why?
|
| Pregnancy | 19 | 2024 | 2355 | 0.870 |
Why?
|
| Suicide | 3 | 2016 | 123 | 0.870 |
Why?
|
| Diabetes, Gestational | 3 | 2022 | 144 | 0.850 |
Why?
|
| Premenstrual Dysphoric Disorder | 2 | 2024 | 8 | 0.840 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2019 | 30 | 0.820 |
Why?
|
| Rural Population | 3 | 2016 | 191 | 0.810 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2022 | 164 | 0.800 |
Why?
|
| Prevalence | 8 | 2024 | 1281 | 0.790 |
Why?
|
| Alcoholic Beverages | 1 | 2021 | 10 | 0.780 |
Why?
|
| Diethylstilbestrol | 1 | 2022 | 49 | 0.780 |
Why?
|
| Chronic Pain | 1 | 2024 | 142 | 0.780 |
Why?
|
| Mental Health | 4 | 2023 | 350 | 0.760 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 85 | 0.750 |
Why?
|
| Environmental Exposure | 5 | 2022 | 205 | 0.740 |
Why?
|
| Incidence | 11 | 2020 | 1237 | 0.730 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 32 | 0.730 |
Why?
|
| Eating | 2 | 2019 | 139 | 0.710 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 2329 | 0.700 |
Why?
|
| Longitudinal Studies | 9 | 2024 | 1225 | 0.690 |
Why?
|
| HIV Infections | 7 | 2023 | 921 | 0.690 |
Why?
|
| Suicidal Ideation | 2 | 2022 | 113 | 0.670 |
Why?
|
| Recreation | 3 | 2017 | 22 | 0.660 |
Why?
|
| Endometriosis | 4 | 2024 | 24 | 0.660 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2019 | 4 | 0.650 |
Why?
|
| Smoking | 7 | 2019 | 830 | 0.650 |
Why?
|
| Zinc | 3 | 2016 | 90 | 0.650 |
Why?
|
| Smoking Cessation | 4 | 2023 | 531 | 0.650 |
Why?
|
| Thinness | 2 | 2017 | 39 | 0.650 |
Why?
|
| United States | 19 | 2024 | 7513 | 0.640 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 78 | 0.640 |
Why?
|
| Ovarian Neoplasms | 4 | 2006 | 135 | 0.640 |
Why?
|
| Dietary Fiber | 2 | 2018 | 86 | 0.630 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 105 | 0.630 |
Why?
|
| Coffee | 2 | 2016 | 19 | 0.630 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2018 | 6 | 0.630 |
Why?
|
| Caffeine | 2 | 2016 | 47 | 0.620 |
Why?
|
| Dogs | 2 | 2012 | 317 | 0.620 |
Why?
|
| Multivariate Analysis | 8 | 2019 | 926 | 0.620 |
Why?
|
| Dietary Carbohydrates | 2 | 2018 | 76 | 0.610 |
Why?
|
| Triglycerides | 1 | 2019 | 242 | 0.580 |
Why?
|
| Biomarkers | 10 | 2023 | 1210 | 0.570 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2018 | 13 | 0.570 |
Why?
|
| Lymphoma | 2 | 2012 | 99 | 0.560 |
Why?
|
| Antidepressive Agents | 4 | 2022 | 229 | 0.560 |
Why?
|
| Coffea | 1 | 2016 | 3 | 0.540 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2007 | 57 | 0.530 |
Why?
|
| Atherosclerosis | 1 | 2018 | 147 | 0.530 |
Why?
|
| Child | 8 | 2024 | 4306 | 0.530 |
Why?
|
| Body Composition | 2 | 2021 | 154 | 0.520 |
Why?
|
| Hypertension | 3 | 2016 | 601 | 0.510 |
Why?
|
| Finland | 4 | 2022 | 20 | 0.510 |
Why?
|
| Seasons | 1 | 2016 | 130 | 0.500 |
Why?
|
| Risk Assessment | 6 | 2018 | 1915 | 0.500 |
Why?
|
| Infertility, Female | 3 | 2024 | 46 | 0.490 |
Why?
|
| Refugees | 3 | 2021 | 65 | 0.490 |
Why?
|
| Aged | 17 | 2024 | 13341 | 0.490 |
Why?
|
| Estrogens | 4 | 2010 | 113 | 0.480 |
Why?
|
| Vitamin B Complex | 2 | 2014 | 22 | 0.480 |
Why?
|
| Linear Models | 8 | 2024 | 422 | 0.480 |
Why?
|
| Androgens | 4 | 2023 | 48 | 0.470 |
Why?
|
| Massachusetts | 14 | 2021 | 2089 | 0.470 |
Why?
|
| Domestic Violence | 1 | 2014 | 35 | 0.460 |
Why?
|
| Crime Victims | 1 | 2014 | 32 | 0.460 |
Why?
|
| Osteoporosis | 2 | 2013 | 137 | 0.460 |
Why?
|
| Estradiol | 5 | 2022 | 242 | 0.460 |
Why?
|
| Sex Offenses | 1 | 2014 | 46 | 0.450 |
Why?
|
| Pregnancy Outcome | 4 | 2022 | 188 | 0.440 |
Why?
|
| Insecticides | 2 | 2012 | 29 | 0.440 |
Why?
|
| Fatty Acids, Essential | 1 | 2013 | 8 | 0.440 |
Why?
|
| Blood Pressure | 1 | 2016 | 522 | 0.440 |
Why?
|
| Folic Acid | 1 | 2014 | 58 | 0.440 |
Why?
|
| Hypersensitivity | 1 | 2014 | 61 | 0.430 |
Why?
|
| Diet Surveys | 5 | 2019 | 77 | 0.430 |
Why?
|
| Iron, Dietary | 1 | 2013 | 11 | 0.430 |
Why?
|
| Osteoporotic Fractures | 1 | 2013 | 32 | 0.430 |
Why?
|
| Overweight | 2 | 2017 | 247 | 0.430 |
Why?
|
| Minerals | 1 | 2013 | 19 | 0.420 |
Why?
|
| Cat Diseases | 2 | 2003 | 16 | 0.420 |
Why?
|
| Potassium | 1 | 2013 | 109 | 0.410 |
Why?
|
| Risk | 6 | 2017 | 372 | 0.400 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2009 | 32 | 0.400 |
Why?
|
| Dysmenorrhea | 1 | 2012 | 8 | 0.400 |
Why?
|
| Prostaglandins | 1 | 2012 | 18 | 0.400 |
Why?
|
| Indians, North American | 1 | 2012 | 26 | 0.390 |
Why?
|
| Bone Development | 1 | 2012 | 33 | 0.390 |
Why?
|
| Obesity | 6 | 2022 | 1186 | 0.380 |
Why?
|
| Mammography | 2 | 2010 | 272 | 0.370 |
Why?
|
| Dog Diseases | 1 | 2012 | 55 | 0.370 |
Why?
|
| Absorptiometry, Photon | 2 | 2010 | 89 | 0.370 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2023 | 34 | 0.370 |
Why?
|
| Vitamin D Deficiency | 3 | 2022 | 50 | 0.360 |
Why?
|
| Social Support | 3 | 2024 | 358 | 0.360 |
Why?
|
| Air Pollutants | 2 | 2022 | 84 | 0.360 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2009 | 16 | 0.350 |
Why?
|
| Calcifediol | 1 | 2010 | 4 | 0.350 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 674 | 0.350 |
Why?
|
| Animals, Domestic | 2 | 2007 | 13 | 0.350 |
Why?
|
| Anxiety Disorders | 2 | 2022 | 188 | 0.340 |
Why?
|
| Attitude to Health | 1 | 2012 | 275 | 0.330 |
Why?
|
| Time Factors | 5 | 2024 | 3579 | 0.330 |
Why?
|
| Asthma | 1 | 2014 | 420 | 0.330 |
Why?
|
| Interleukin-6 | 4 | 2019 | 309 | 0.330 |
Why?
|
| Anxiety | 3 | 2023 | 395 | 0.330 |
Why?
|
| Life Style | 3 | 2019 | 328 | 0.300 |
Why?
|
| Cotinine | 1 | 2007 | 18 | 0.300 |
Why?
|
| Male | 20 | 2024 | 27572 | 0.290 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 258 | 0.290 |
Why?
|
| Micronutrients | 2 | 2018 | 29 | 0.290 |
Why?
|
| Cause of Death | 2 | 2024 | 200 | 0.280 |
Why?
|
| Health Behavior | 1 | 2010 | 473 | 0.280 |
Why?
|
| Child Abuse | 2 | 2022 | 87 | 0.280 |
Why?
|
| Health Status | 1 | 2009 | 449 | 0.270 |
Why?
|
| Child Abuse, Sexual | 2 | 2018 | 21 | 0.260 |
Why?
|
| Dihydroxycholecalciferols | 1 | 2005 | 2 | 0.250 |
Why?
|
| Flax | 3 | 2011 | 7 | 0.250 |
Why?
|
| Antioxidants | 1 | 2007 | 243 | 0.250 |
Why?
|
| Alaska | 3 | 2016 | 6 | 0.250 |
Why?
|
| Hydrocortisone | 2 | 2024 | 188 | 0.250 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 264 | 0.250 |
Why?
|
| Pregnancy Complications | 3 | 2017 | 391 | 0.240 |
Why?
|
| Bisexuality | 1 | 2024 | 14 | 0.240 |
Why?
|
| Sweating | 1 | 2024 | 26 | 0.240 |
Why?
|
| Homosexuality, Female | 1 | 2024 | 21 | 0.240 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2069 | 0.230 |
Why?
|
| Bhutan | 5 | 2022 | 20 | 0.230 |
Why?
|
| Ultraviolet Rays | 2 | 2022 | 125 | 0.230 |
Why?
|
| Receptors, Calcitriol | 3 | 2009 | 32 | 0.230 |
Why?
|
| India | 2 | 2024 | 157 | 0.220 |
Why?
|
| Psychological Tests | 1 | 2024 | 50 | 0.220 |
Why?
|
| Sweden | 4 | 2024 | 42 | 0.220 |
Why?
|
| Nails | 1 | 2024 | 38 | 0.220 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2019 | 384 | 0.220 |
Why?
|
| Selenium | 1 | 2023 | 25 | 0.210 |
Why?
|
| Breast Diseases | 2 | 2021 | 39 | 0.210 |
Why?
|
| Mouth Neoplasms | 1 | 2003 | 31 | 0.210 |
Why?
|
| Pregnant Women | 2 | 2017 | 92 | 0.210 |
Why?
|
| Contraceptive Agents | 1 | 2022 | 11 | 0.210 |
Why?
|
| Live Birth | 1 | 2022 | 24 | 0.210 |
Why?
|
| Pediatric Obesity | 1 | 2024 | 93 | 0.210 |
Why?
|
| Child, Preschool | 3 | 2024 | 1839 | 0.210 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 29 | 0.210 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2023 | 17 | 0.200 |
Why?
|
| Mass Screening | 1 | 2007 | 647 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 158 | 0.200 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 36 | 0.190 |
Why?
|
| Body Height | 1 | 2022 | 75 | 0.190 |
Why?
|
| Birth Weight | 1 | 2022 | 83 | 0.190 |
Why?
|
| Follicular Atresia | 1 | 2021 | 3 | 0.190 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2017 | 27 | 0.190 |
Why?
|
| Confidence Intervals | 4 | 2012 | 256 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2003 | 233 | 0.190 |
Why?
|
| Racism | 1 | 2022 | 81 | 0.190 |
Why?
|
| Weight Gain | 1 | 2022 | 161 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 159 | 0.180 |
Why?
|
| Contraception | 1 | 2021 | 64 | 0.180 |
Why?
|
| Depressive Disorder | 2 | 2014 | 293 | 0.180 |
Why?
|
| Puberty | 1 | 2021 | 57 | 0.180 |
Why?
|
| Air Pollution | 1 | 2020 | 34 | 0.180 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 1449 | 0.180 |
Why?
|
| Cytokines | 2 | 2015 | 906 | 0.180 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2020 | 94 | 0.180 |
Why?
|
| Mental Disorders | 2 | 2022 | 766 | 0.170 |
Why?
|
| Prognosis | 2 | 2015 | 1572 | 0.160 |
Why?
|
| Work Schedule Tolerance | 1 | 2019 | 26 | 0.160 |
Why?
|
| Dyslipidemias | 1 | 2019 | 34 | 0.160 |
Why?
|
| Suicide, Attempted | 3 | 2022 | 103 | 0.160 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2018 | 4 | 0.160 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 19 | 0.160 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 50 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 809 | 0.150 |
Why?
|
| Sexual Behavior | 1 | 2020 | 183 | 0.150 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2011 | 84 | 0.150 |
Why?
|
| Epidemiologic Studies | 1 | 2018 | 36 | 0.150 |
Why?
|
| Body Weight | 2 | 2017 | 378 | 0.150 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2018 | 9 | 0.150 |
Why?
|
| Abdominal Fat | 1 | 2017 | 6 | 0.150 |
Why?
|
| Puerto Rico | 6 | 2017 | 227 | 0.150 |
Why?
|
| Stearic Acids | 1 | 2017 | 8 | 0.150 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1032 | 0.150 |
Why?
|
| Infant, Newborn | 6 | 2021 | 1311 | 0.150 |
Why?
|
| Age of Onset | 1 | 2018 | 172 | 0.140 |
Why?
|
| ROC Curve | 1 | 2018 | 259 | 0.140 |
Why?
|
| Interleukin-4 | 2 | 2015 | 138 | 0.140 |
Why?
|
| Sex Distribution | 2 | 2016 | 254 | 0.140 |
Why?
|
| Serum Albumin | 1 | 2017 | 38 | 0.140 |
Why?
|
| Age Distribution | 2 | 2016 | 261 | 0.140 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2019 | 367 | 0.140 |
Why?
|
| Interleukin-12 | 2 | 2015 | 124 | 0.140 |
Why?
|
| Interleukin-2 | 2 | 2015 | 164 | 0.140 |
Why?
|
| DNA Helicases | 1 | 2019 | 187 | 0.140 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 43 | 0.130 |
Why?
|
| Tea | 1 | 2016 | 26 | 0.130 |
Why?
|
| Double-Blind Method | 2 | 2022 | 680 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2017 | 205 | 0.130 |
Why?
|
| Nepal | 3 | 2023 | 93 | 0.130 |
Why?
|
| Interferon-gamma | 2 | 2015 | 539 | 0.130 |
Why?
|
| Interviews as Topic | 2 | 2020 | 486 | 0.120 |
Why?
|
| Progesterone | 2 | 2014 | 157 | 0.120 |
Why?
|
| Insulin | 2 | 2017 | 687 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2017 | 471 | 0.120 |
Why?
|
| Trauma Severity Indices | 1 | 2014 | 38 | 0.120 |
Why?
|
| Ovulation Detection | 1 | 2014 | 4 | 0.120 |
Why?
|
| Anovulation | 1 | 2014 | 8 | 0.120 |
Why?
|
| Nurse Midwives | 1 | 2014 | 11 | 0.120 |
Why?
|
| Ovulation | 1 | 2014 | 28 | 0.120 |
Why?
|
| Socioeconomic Factors | 3 | 2012 | 781 | 0.110 |
Why?
|
| Luteinizing Hormone | 1 | 2014 | 95 | 0.110 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 43 | 0.110 |
Why?
|
| Midwifery | 1 | 2014 | 35 | 0.110 |
Why?
|
| Urban Population | 1 | 2015 | 182 | 0.110 |
Why?
|
| Reproductive Health | 1 | 2014 | 24 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2012 | 576 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2017 | 404 | 0.110 |
Why?
|
| Maternal Exposure | 1 | 2014 | 40 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2023 | 919 | 0.110 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 33 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2011 | 11 | 0.110 |
Why?
|
| Chemokines | 1 | 2014 | 94 | 0.110 |
Why?
|
| Fertility | 2 | 2024 | 85 | 0.110 |
Why?
|
| Health Promotion | 3 | 2022 | 491 | 0.100 |
Why?
|
| Cats | 2 | 2003 | 81 | 0.100 |
Why?
|
| Mastodynia | 1 | 2012 | 3 | 0.100 |
Why?
|
| Animals | 5 | 2012 | 19661 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 669 | 0.100 |
Why?
|
| Mexico | 1 | 2012 | 42 | 0.100 |
Why?
|
| Irritable Mood | 1 | 2012 | 15 | 0.100 |
Why?
|
| Community Mental Health Centers | 1 | 2012 | 18 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 1243 | 0.100 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 104 | 0.100 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2012 | 86 | 0.100 |
Why?
|
| Back Pain | 1 | 2012 | 51 | 0.100 |
Why?
|
| Abdominal Pain | 1 | 2012 | 92 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 282 | 0.100 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2012 | 51 | 0.100 |
Why?
|
| Particulate Matter | 2 | 2022 | 59 | 0.090 |
Why?
|
| Central Nervous System Stimulants | 1 | 2011 | 63 | 0.090 |
Why?
|
| Nutrition Assessment | 2 | 2010 | 58 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2011 | 55 | 0.090 |
Why?
|
| Riboflavin | 1 | 2011 | 14 | 0.090 |
Why?
|
| C-Peptide | 1 | 2011 | 23 | 0.090 |
Why?
|
| Thiamine | 1 | 2011 | 19 | 0.090 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 152 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 436 | 0.090 |
Why?
|
| Polymorphism, Genetic | 2 | 2009 | 197 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2014 | 838 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2023 | 524 | 0.090 |
Why?
|
| Quality of Health Care | 1 | 2014 | 519 | 0.080 |
Why?
|
| Seasonal Affective Disorder | 1 | 2009 | 2 | 0.080 |
Why?
|
| Biogenic Monoamines | 1 | 2009 | 5 | 0.080 |
Why?
|
| Glucose Intolerance | 1 | 2010 | 88 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 196 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2010 | 484 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2012 | 735 | 0.080 |
Why?
|
| Sunlight | 1 | 2009 | 29 | 0.080 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2017 | 37 | 0.080 |
Why?
|
| Algorithms | 1 | 2014 | 990 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2010 | 306 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2010 | 283 | 0.070 |
Why?
|
| Energy Intake | 2 | 2024 | 213 | 0.070 |
Why?
|
| Heart Failure | 1 | 2015 | 867 | 0.070 |
Why?
|
| Sex Factors | 2 | 2023 | 960 | 0.070 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2006 | 59 | 0.070 |
Why?
|
| Colonic Polyps | 1 | 2006 | 26 | 0.070 |
Why?
|
| Prolactin | 1 | 2006 | 40 | 0.070 |
Why?
|
| Comorbidity | 1 | 2009 | 1091 | 0.070 |
Why?
|
| Lactose | 1 | 2006 | 13 | 0.060 |
Why?
|
| Infant, Low Birth Weight | 2 | 2017 | 58 | 0.060 |
Why?
|
| Diet Records | 1 | 2005 | 47 | 0.060 |
Why?
|
| Perception | 1 | 2006 | 179 | 0.060 |
Why?
|
| Europe | 1 | 2005 | 183 | 0.060 |
Why?
|
| New Hampshire | 1 | 2024 | 42 | 0.060 |
Why?
|
| Meals | 1 | 2024 | 21 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1463 | 0.060 |
Why?
|
| Pregnancy Trimester, First | 2 | 2017 | 29 | 0.060 |
Why?
|
| Fast Foods | 1 | 2024 | 15 | 0.060 |
Why?
|
| Food Handling | 1 | 2024 | 45 | 0.060 |
Why?
|
| Hazardous Substances | 1 | 2003 | 16 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 254 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2024 | 150 | 0.050 |
Why?
|
| Testosterone | 1 | 2023 | 111 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2021 | 6009 | 0.050 |
Why?
|
| Benzene | 1 | 2022 | 7 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2022 | 32 | 0.050 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 6 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 675 | 0.050 |
Why?
|
| Estrone | 1 | 2022 | 12 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 108 | 0.050 |
Why?
|
| Reproductive History | 1 | 2022 | 15 | 0.050 |
Why?
|
| Ovarian Reserve | 1 | 2021 | 8 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2012 | 5183 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 741 | 0.050 |
Why?
|
| Brain | 1 | 2009 | 1489 | 0.050 |
Why?
|
| Pain | 1 | 2024 | 406 | 0.040 |
Why?
|
| Registries | 1 | 2024 | 803 | 0.040 |
Why?
|
| Parents | 1 | 2024 | 380 | 0.040 |
Why?
|
| Glucose Tolerance Test | 2 | 2010 | 98 | 0.040 |
Why?
|
| Problem Solving | 1 | 2020 | 30 | 0.040 |
Why?
|
| Poverty | 2 | 2015 | 286 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2018 | 13 | 0.040 |
Why?
|
| Psychological Trauma | 1 | 2018 | 21 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2022 | 387 | 0.040 |
Why?
|
| Dominican Republic | 1 | 2017 | 23 | 0.040 |
Why?
|
| Quality of Life | 1 | 2024 | 1117 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2017 | 25 | 0.040 |
Why?
|
| Educational Status | 2 | 2008 | 271 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 39 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2020 | 612 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1551 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2017 | 174 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 723 | 0.030 |
Why?
|
| Mice | 1 | 2009 | 10280 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2015 | 39 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 2015 | 82 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Yogurt | 1 | 2015 | 5 | 0.030 |
Why?
|
| Pakistan | 1 | 2015 | 14 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2015 | 35 | 0.030 |
Why?
|
| Seafood | 1 | 2015 | 18 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 84 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 72 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 123 | 0.030 |
Why?
|
| Urinalysis | 1 | 2014 | 33 | 0.030 |
Why?
|
| Vegetables | 1 | 2015 | 91 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 72 | 0.030 |
Why?
|
| Fruit | 1 | 2015 | 121 | 0.030 |
Why?
|
| New York | 1 | 2014 | 137 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 265 | 0.030 |
Why?
|
| Research | 1 | 2014 | 191 | 0.030 |
Why?
|
| Data Collection | 1 | 2014 | 384 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 581 | 0.020 |
Why?
|
| Leisure Activities | 1 | 2011 | 28 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2014 | 352 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2011 | 55 | 0.020 |
Why?
|
| Hydroxyestrones | 1 | 2010 | 4 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2011 | 180 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 298 | 0.020 |
Why?
|
| Censuses | 1 | 2008 | 14 | 0.020 |
Why?
|
| Maternal Age | 1 | 2008 | 34 | 0.020 |
Why?
|
| Marital Status | 1 | 2008 | 43 | 0.020 |
Why?
|
| Patient Selection | 1 | 2010 | 446 | 0.020 |
Why?
|
| Mortality | 1 | 2008 | 159 | 0.020 |
Why?
|
| Employment | 1 | 2008 | 136 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 178 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 208 | 0.020 |
Why?
|
| Genotype | 1 | 2005 | 642 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 454 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 5089 | 0.010 |
Why?
|